Adents, provider of serialization and track & trace solutions, introduced Adents Verification Router Service Solution, as per upcoming U.S. pharmaceuticals serialization requirements. The solution works through blockchain-based Adents NovaTrack product.
A Verification Router Service, or VRS, is one of a series of milestone requirements that will come into play during the next phase of the Drug Supply Chain Security Act. Beginning in late November 2019, no returned serialized product may be resold until the wholesale distributor verifies that product’s unique identifiers, including the SNI for each sealed homogeneous case or package. A VRS is an interoperable solution used to manage the acceptance, formatting, and delivery of requests and responses to support these DSCSA verification requirements, as well as other business requirements defined between trading partners.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.